The Genetic Risk of Cancer Therapy
DOI:
https://doi.org/10.32635/2176-9745.RBC.2000v46n2.3410Keywords:
Genetic Risk, Radiotherapy, Brachytherapy, ChemotherapyAbstract
The presente paper indicates the effects of the most common practices for cancer treatment on the genetic sample of the patient. The main objective of this report is to stress the importance of the risk/benefit assessment of the different therapeutic protocols adopted for cancer and the need for the development of new therapeutic practices and chemotherapy agents. After stressing the fact that cancer is a genetic disease that develops through multiple steps, the effects of ionizing radiation and of some therapeutic Chemicals on the DNA are presented. Besides, the deleterious effects on the DNA of the technical personnel who provides treatment are also indicated. Therefore, this paper discusses tn a general way the genetic damage induced by anti-neoplastic agents, which increases the risk for the development of another primary tumor.
Downloads
References
COTRAN, R.S.; KUMAR, V.; COLLINS, T. - Neoplasias. In: Cotran, R.S.; Kumar, V.; Collins, T. eds. Robbins Pathologic Basis of Disease, 6th ed. Philadelphia: WB Saudenrs, 329-402, 1999.
VENKATACHALAM, R; PAUL, S.F.D.; MOHANKUMAR, M.N.; et al- Higher frequency of dicentrics and micronuclei in peripheral blood lymphocytes of cancer patients. Mutat. Res., 425: 1-8, 1999. DOI: https://doi.org/10.1016/S0027-5107(98)00238-3
ANTOINE, G.B.; GERBER, G.B.; LEONARD, A.; RICHARD, R; WAMBERSIE, A. – Ghromosome aberration in patients treated with telecobalt therapy tor mammary carcinoma. Radiat. Res., 86: 171-177, 1981. DOI: https://doi.org/10.2307/3575608
BYRNE, J.- Long-term genetic and reproductive effects of ionizing radiation and hemotherapeutic agents on cancer patients and their offspring. Teratology., 59: 210-215, 1999. DOI: https://doi.org/10.1002/(SICI)1096-9926(199904)59:4<210::AID-TERA4>3.0.CO;2-X
KAISER, H.E.; NASIR, A.; GROGER, A.M.; LINK, G.J.Jr. - The etiology of second primary tumor. In Vivo, 12:89-93, 1998.
TRAVIS, L.B.; CURTIS, R.E.; GLIMELIUS, B.; et al. - Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin’s lymphoma. J. Natl. Cancer Inst., 87: 524-530, 1995. DOI: https://doi.org/10.1093/jnci/87.7.524
KOISHI, S.; KUBOTA, M.; SAWADA, M.; et al -Biomarkers in long survivors of pediatric acure lymphoblastic leukemia patients: late effects of cancer therapy Mutat Res., 422: 213-222, 1998. DOI: https://doi.org/10.1016/S0027-5107(98)00199-7
ELKING, M.M. - Repair processes in radiation biology. Radiat. Res., 100: .425-449, 1984. DOI: https://doi.org/10.2307/3576409
ALVARES, L.C.; FREITAS, J.A.S.; TAVANO, O. - Considerações gerais: fundamentos da radiologia. In: Alvares, L.C.; Tavano, O. Curso de Radiologia em Odontologia. São Paulo: Santos, p.1-16, 1987.
ENGELS, H; WAMBERSIE, A. - Relative biological effectiveness of nêutrons for cancer induction and other late effects: a review of biological data. Recent Results Cancer Res., 150: 54-87,1998. DOI: https://doi.org/10.1007/978-3-642-78774-4_3
PHIL, A.; ELDJARAN, L. – Pharmacological pects of ionizing radiation and chemical protection in Pharmacol. Res, 10:437-4, 1958.
NARATAJAN, A.T.; OBE, G.- Molecular mechanisms involved in the production of chromosomal aberrations. 1. Utilization of neurospora endonucleases for the study of aberration production in G2 stages of the cell cycle. Mutat. Res., 52:137-149, 1978.
LANE, D. -p53, Guardian of the genoma. Nature, 358: 15-16, 1992. DOI: https://doi.org/10.1038/358015a0
KLEINERMAN, R.A.; BOICE, J.D.; STORM, H.H.; et al - Second primary cancer after treatment for cervical cancer. Cancer, 76: 442-452, 1995. DOI: https://doi.org/10.1002/1097-0142(19950801)76:3<442::AID-CNCR2820760315>3.0.CO;2-L
BHATIA, S.; ROBISON, L.L.; OBERLIN, O.; et al- Breast cancer and other second neoplasm after childhood Hodgkins disease. New Engl. J. Med., 334: 745-751, 1996. DOI: https://doi.org/10.1056/NEJM199603213341201
PEREL, Y; LEVERGER, G.; CARRERE, A. et al - Second thyroid neoplasms after prophylactic cranial irradiarion for acute lymphoblastic leukemia. Am. J. ElematoL, 59: 91-94, 1998. DOI: https://doi.org/10.1002/(SICI)1096-8652(199809)59:1<91::AID-AJH18>3.0.CO;2-4
MITCHELL, M.J.; LOGAN, M.- Radiation-induces changes in bone. Radiographics, 18: 1125-1136, 1998. DOI: https://doi.org/10.1148/radiographics.18.5.9747611
POLLYCOVE, M. Nonlinearity of radiation health effects. Environ. Elealth Perspect., 106: 363-368, 1998. DOI: https://doi.org/10.1289/ehp.98106s1363
Da CRUZ, A.D.; MCARTHUR, A.G.; SILVA, C.C.; CURADO, M.P.; GLICKMAN, B.W.- Human micronucleus counts are correlated with age, smoking, and cesium-137 dose in Goiania (Brazil) radiological accident. Mutat. Res.,313: 57-68, 1994. DOI: https://doi.org/10.1016/0165-1161(94)90033-7
RAMALHO, A.; CURADO, M.; NATARAJAN, A.T.- Lifespan of human lymphocytes estimated during asix year cytogenetic follow-up of individuais accidenrally exposed in the 1987 radiological accident in Brazil. Mutat. Res., 331:47-54, 1995. DOI: https://doi.org/10.1016/0027-5107(95)00049-O
RAMALHO, A.T.; COSTA, M.L.; OLIVEIRA, M.S. - Convetional radiation-biological dosimetry using frequencies of unstable chromosome aberrarions. Mutat. Res., 404:97-100, 1998. DOI: https://doi.org/10.1016/S0027-5107(98)00099-2
SADDI, V.; CURRY, J.; NOHTURFFT, A.; WOLFGANG, K.; GLICKMAN, B.W.- Increased hprt mutant frequencies in brasilian children accidentally exposed to ionizing radiation. Environ. Mol. Mutagen., 28: 267-275, 1996. DOI: https://doi.org/10.1002/(SICI)1098-2280(1996)28:3<267::AID-EM11>3.0.CO;2-D
SKANDALIS, A.; CRUZ, A.D.; CURRY, J.; NOHTURFFT, A.; CURADO, M.P; GLICKMAN, B.W. - Molecular analysis of T-lymphocyte HPRT mutations in individuals exposed ionizing radiation in Goiânia, Brazil. Environ. Mol. Mutagenesis, 29:107-116, 1997. DOI: https://doi.org/10.1002/(SICI)1098-2280(1997)29:2<107::AID-EM1>3.0.CO;2-B
AISEN, S.; CARVALHO, H.A.; ADDAD, C.M.K. - Aplicações Clínicas. In: Salvajoli, J.V; Souhami, L.; Faria, S.L. Editores. Radioterapia em Oncologia, Parte B, Rio de Janeiro, Medsi, 190-218, 1999.
BIRKENHAKE, S.; SAUER, R. - Historical essentials in influencing the development of radiooncology in the past 100 years. Experientia, 51: 681-685, 1995. DOI: https://doi.org/10.1007/BF01941265
BLEUER, J.P; AVERKIN, Y.L; ABELIN, T.- Chernobyl related thyreoid cancer: what evidence for role of short lived iodines?. Envirom Health Perspec.t, 105: 1483-1578, 1997. DOI: https://doi.org/10.2307/3433656
GOLDMAN, M.- The russian radiation legacy: its integrated impact and lessons. Environ. Health. Perspect., 105: 1385-1391, 1997. DOI: https://doi.org/10.1289/ehp.97105s61385
FENECH, M.; PEREPETSKAYA, G.; MIKHALEVICH, L.A.- More comprehensive application of the micronucleus technique for biomonitoring of genetic damage rates in human populations-experiences from the Chernobyl Catástrofe. Environ. Mol. Mutagen.,; 30: 112-118, 1997. DOI: https://doi.org/10.1002/(SICI)1098-2280(1997)30:2<112::AID-EM3>3.0.CO;2-P
OGILVY-STUARX A.L; SHALET, S.M.- Effect of radiation on the human reproductive system. Environ. Health Perspect., 101: 109-116, 1993. DOI: https://doi.org/10.1289/ehp.93101s2109
FISHBEIN, A.; ZABLUDOVSKY, N.; ELTES, F; VALENTIN, G.; BARTOOV, B. – Ultramorphological sperm characteristics in the risk assessment of health effects after radiation exposure among salvage works in Chernobyl. Environ. Health. Perspect., 105: 1445-1449, 1997. DOI: https://doi.org/10.1289/ehp.97105s61445
RAMIREZ, M.J.; SURRALES, J.; GALOFRE, R; CREUS, A.; MARCOS, R. - Radioactive iodine induces clastogenic and age-dependent aneugenic effects in lymphocytes of thyroid cancer patients as revealed by interphase FISH. Mutagenesis, 12: 449-55, 1997. DOI: https://doi.org/10.1093/mutage/12.6.449
CLETON, F.J.-Chemotherapy general aspects. In: Peckham, M.; Pinedo, H.M.; Veronesi, U. Oxford Textbook of Oncology, Oxford: Oxford Medical Publications, v. 1, 445-468, 1995.
TUCKER, J.D.; WYROBEK, A.J.; ASHWORTH, L.K.; et al.- Induction, accumulation, and persistence ofsister chromatid exchanges in women with breast cancer receiving cyclophosphamide, adriamycin, and 5-fluorouracil chemotherapy. Cancer Res., 50: 4951-4956, 1990.
OSANTO, S.; THIJSSEN, J.C.; WOLDERING, V.M.; van RIJN, J.L.S.; NATARAJAN, A.T.; TATES, A.D.- Increased frequency of chromosomal damage in peripheral blood lymphocytes up to nine years following curative chemotherapy of patients with testicular carcinoma Environ. Mol. Mutagenesis, 17:71-78, 1991. DOI: https://doi.org/10.1002/em.2850170202
FERGUSON, L.R.; DENNY, W.A – Anticancer drugs an underestimated risk or an underutilised resource in mutagenesis?. Mutat. Res., 331:1-26, 1995. DOI: https://doi.org/10.1016/0027-5107(95)00063-O
WORKMAN:, LEWIS, A .D.; CASSIDY, J. Alkylating agents and related drugs. In: Peckham, M.; Pinedo, H.M.; Veronesi, U. Oxford Textbook of Oncology. Oxford: Oxford Medical Publications, 1: 495-513, 1995.
RALPH, R.K.; JUDD, W; POMMIER, Y; et al.- DNA topoisomerases. In: Neidle, S.; Waring, M, J. Topics in Molecular and Structural Biology Molecular Aspects of Anticancer Drug- DNA Interactions. 2 ed. London: MacMillan, 1-95, 1994. DOI: https://doi.org/10.1007/978-1-349-13330-7_1
DE LA INGLESIA, EA .; FITZGERALD, J.E.; McGUIRE, E.J.; KIM, S.N.; HEIFETZ, C.L.; STONER, G.D.- Bacterial and mamalian cell mutagenesis, sister-chromatid exchange and mouse lung adenoma bioassay with the antineoplastic acridine derivative.y. Toxicol. Environ. Health, 14:. 667-681, 1984. DOI: https://doi.org/10.1080/15287398409530616
PEDERSEN-BJERGAARD, J.; PHILIP:- Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase-II. Blood, 78: 1147-48, 1991a. DOI: https://doi.org/10.1182/blood.V78.4.1147.bloodjournal7841147
SANDOVAL, C.; PUI, C.H.; BOWMAN, L.C. et al. Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase-II inhibitors, and irradiation. J. Clin. OncoL, 11: 1039-1045, 1993. DOI: https://doi.org/10.1200/JCO.1993.11.6.1039
PEDERSEN-BJERGAARD, PHILIP: - Two different classes of therapy-related and de-novo acute leukemia? Cancer Cytogenet., 55:1 19-24, 1991b. DOI: https://doi.org/10.1016/0165-4608(91)90246-Q
SANDOVAL, C.; HEAD, D.H.; MIRRO, J. -The t(9;11)(p21;q23) in pediatric de novo and second ary acute myeloblastic leukemia. Leukemia, 6: 513-519, 1992.
DE FLORA, S.; RAMEL, C. Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overview. Mutat. Res., 202: 285-306, 1988 DOI: https://doi.org/10.1016/0027-5107(88)90193-5
MENEGHINI, R. - Genotoxicity of active oxygen species in mammalin cells. Mutat. Res., 195: 215-230, 1988. DOI: https://doi.org/10.1016/0165-1110(88)90001-2
JORDAN, M.A.; THROWER, D.; WILSON, L. - Effects of vinblastine, phodoohyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis. J Cell Sci, 102: 401-16, 1992. DOI: https://doi.org/10.1242/jcs.102.3.401
WENDELL, K.L.; WILSON, L.; JORDAN, M.A. - Mitotic block in HeLa cells by vinblastine ultrastrutural changes in kinetochore-microtubule attachment and in centrosomes. J Cell Sci, 104: 261-274, 1993. DOI: https://doi.org/10.1242/jcs.104.2.261
LONG, B.H.; FAIRCHILD, C.R.- Paclitaxel inhibits progression of mitotic cells to g(1) phase by interference with spindle formation without affecting other microtubule functions during anaphase and telophase. Câncer Res., 54: 4355-4361, 1994.
TINWELL, H.; ASHBJ.- Genetic toxicity and potencial carcinogenicity of taxol. Carcinogenesis, 15:1499-1501, 1994. DOI: https://doi.org/10.1093/carcin/15.8.1499
NATARAJAN, A.T.; DUIVENVOORDEN, W.C.; MEIJERS, M.; ZWANENBURG, T.S.- Induction of mitotic aneuploidy using Chinese hamster primary embryonic cells. Test results of 10 Chemicals. Mutat. Res., 287: 47-56, 1993. DOI: https://doi.org/10.1016/0027-5107(93)90144-5
DAHER, G.C.; HARRIS, B.E.; DIASIO, R.B.; Metabolism of pyrimidine analogues and their nucleosides. Pharmacol. Ther., 48: 189-222, 1990. DOI: https://doi.org/10.1016/0163-7258(90)90080-L
GENTHER, C.S.; SGHOENY, R.S.; LOPER, J.C.; SMITH, G.G..- Mutagenic studies of folic and antagonists Antimicrob. Agents. Chemother., 12: 84-92, 1977. DOI: https://doi.org/10.1128/AAC.12.1.84
CLIVE, D.; GLOVER, P; APPLEGATE, M.; HOZIER, J.- Molecular aspects of chemical mutagenesis in L5178Y/tk +/- mouse lymphoma cells. Mutagenesis, 5: 191-197, 1990. DOI: https://doi.org/10.1093/mutage/5.2.191
HOCHHAUSER, D.- Modulation of chemosensitivity through altered expression of cell cycle regulatory genes in cancer. Anticancer Drugs, 8: 903-910, 1997. DOI: https://doi.org/10.1097/00001813-199711000-00001
NATH, J.; KRISHNA, G.- Safety screening of drugs in cancer Acta Haematolügica, 99:138-147, 1998. DOI: https://doi.org/10.1159/000040828
GRUMMT, T.; GRUMMT, H.J.; SCHOTT, G. - Chromosomal aberrations in peripheral lymphocytes of nurses and physicians handling antineoplastic drugs Res., 302: 19-24, 1993. DOI: https://doi.org/10.1016/0165-7992(93)90085-A
HIRST, M.; MILLS. D.G.; TSE, S.; LEVIN, L.; WHITI, D.F. - Occupational exposure to cyclophosphamide. Lancet, 1: 186-188, 1984. DOI: https://doi.org/10.1016/S0140-6736(84)92111-1
SIEBERT, S.; ADAMSON, R.H. - Toxicity of antineoplastic agents in man: chromosomal aberrations, antifertility effects, congenital malformations and carcinogenic potential. Adv. Cancer Res., 21-57-155, 1975. DOI: https://doi.org/10.1016/S0065-230X(08)60176-1
SELEVEN, S.G.; LINDBOHM, M.L.; HORNUNG, R.W.; HEMMINKI, K. - A study of occupational exposure to antineoplastic drugs and fetal loss in nurse. New. Engl. J. Med., 313: 1 173-1 178, 1985. DOI: https://doi.org/10.1056/NEJM198511073131901
BOS, R.P.; LEENARS, A.O.; THEUWS, P.T.; HENDERSON, PT. - Mutagenecity of urine from nurses handling cytostatic drugs, influence of smoking. Int. Arch. Occup. Environ. Health., 50: 359-369, 1982. DOI: https://doi.org/10.1007/BF00377832
ÜNDEGER, Ü.; BASARAN, N.; KARS, A.; GÚÇ, D. - Assessment of DNA damage in nurses handling antineoplastic drugs by the alcaline COMET assay. Mutat. Res., 439:277-285, 1999. DOI: https://doi.org/10.1016/S1383-5718(99)00002-9
ANWAR, WA.; SALAMA, S.I.; EL SERAFY, M.M.; HEMIDA, S.A.; HAFEZ, A.S.- Chromosomal aberrations and micronucleus frequency in nurses occupationally exposed to cytotoxic drugs Mutagenesis, 9: 315-317, 1994. DOI: https://doi.org/10.1093/mutage/9.4.315
NORPPA, H.; SORSA, M.; VAINIO, H.; et al.- Increased sister chromatid Exchange frequencies in lymphocytes of nurses hadling cytostaic drugs. Scand. J. Work. Environ. Health, 6: 299-301, 1980. DOI: https://doi.org/10.5271/sjweh.2605
RICH, D.C.; CORPIO, C.A.; SMITH, M.B.; BEACK, C.T; LALLY, K.P; ANDRASSY, R.J.- Second malignant neoplasms in children after treatment of soft tissue sarcoma. J. Pediatr. Sug., 32: 369-372, 1997. DOI: https://doi.org/10.1016/S0022-3468(97)90213-X
